Infections récidivantes chez les patients greffés immunodéprimés

SPECIAL REPORT

HIV / AIDS

11^e Conférence de la Société internationale sur le SIDA (IAS) 2021

Bacterial Infections

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

Clin Microbiol Infect.

Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy JR, Daneman N

doi: 10.1016/j.cmi.2020.07.016.

SPECIAL REPORT

Fungal InfectionsViral Infections, Non-HIV

Les patients peuvent profiter de l’amphotéricine B liposomale

Bacterial InfectionsSepsis

Impact of baseline characteristics on future episodes of bloodstream infections: Multistate model in septic patients with bloodstream infections

Clin Infect Dis.

Vazquez Gusillamet MC, Vazquez R, Noe J, Micek ST, Fraser VJ, Kollef MH

doi: 10.1093/cid/ciz1206.

Bacterial Infections

Staphylococcus aureus Bloodstream Infection in Patients With Prosthetic Joints in the Prospective VIRSTA Cohort Study: Frequency and Time of Occurrence of Periprosthetic Joint Infection

Open Forum Infect Dis.

Dufour S, Piroth L, Chirouze C, Tattevin P, Becker A, Braquet P, Ferry T, Duval X, Le Moing V, VIRSTA/AEPEI Study Group.

doi: 10.1093/ofid/ofz515.

Viral Infections, Non-HIV

Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7)

Lancet Infect Dis.

Mikulska M, Cesaro S, de Lavallade H, Di Blasi R, Einarsdottir S, Gallo G, Rieger C, Engelhard D, Lehrnbecher T, Ljungman P, Cordonnier C, European Conference on Infections in Leukaemia group

doi: 10.1016/S1473-3099(18)30601-7.

Fungal Infections

Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study

Lancet Infect Dis.

Mejia-Chew C, O'Halloran JA, Olsen MA, Stwalley D, Kronen R, Lin C, Salazar AS, Larson L, Hsueh K, Powderly WG, Spec A

doi: 10.1016/S1473-3099(19)30405-0.

Viral Infections, Non-HIV

Human Herpesvirus 6 Infection after Autologous Stem Cell Transplantation: A Multicenter Prospective Study in Adult Patients

J Infect.

Balsat M, Pillet S, Tavernier E, Cacheux V, Escuret V, Moluçon-Chabrot C, Augeul-Meunier K, Mirand A, Regagnon C, Tinquaut F, Bousser V, Oriol M, Guyotat D, Salles G, Bay JO, Pozzetto B, Cornillon J

doi: 10.1016/j.jinf.2019.05.001.

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

Lancet Infect Dis.

Guery B, Menichetti F, Anttila VJ, Adomakoh N, Aguado JM, Bisnauthsing K, Georgopali A, Goldenberg SD, Karas A, Kazeem G, Longshaw C, Palacios-Fabrega JA, Cornely OA, Vehreschild MJGT; EXTEND Clinical Study Group

doi: 10.1016/

Related content

11e Conférence de la Société internationale sur le SIDA (IAS) 2021

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

Les patients peuvent profiter de l’amphotéricine B liposomale

Impact of baseline characteristics on future episodes of bloodstream infections: Multistate model in septic patients with bloodstream infections

Staphylococcus aureus Bloodstream Infection in Patients With Prosthetic Joints in the Prospective VIRSTA Cohort Study: Frequency and Time of Occurrence of Periprosthetic Joint Infection

Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7)

Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study

Human Herpesvirus 6 Infection after Autologous Stem Cell Transplantation: A Multicenter Prospective Study in Adult Patients

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

11^e Conférence de la Société internationale sur le SIDA (IAS) 2021